To include your compound in the COVID-19 Resource Center, submit it here.

Genasense oblimersen sodium injection: Additional Phase III data

Additional data from the double-blind, international Phase III AGENDA trial in 314 patients showed that

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE